IMA earnings: next report 2026-07-23, real EPS beat/miss history, analyst consensus Buy, P/E -1.29. Updated 2026-07-23.
ImageneBio (IMA) Research Hub
ImageneBio (IMA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 5.08 USD (+1.40%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.29, market cap 0.07B. This hub links to the full technical, earnings and options research available for IMA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.08 USD (+1.40%) |
| 52-week range | 4.73 USD – 6.3 USD |
| Trend regime | Range |
| 14-day RSI | 34.5 (Bearish) |
| Trailing P/E | -1.29 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-23 |
Available research for IMA
Covered Call on IMA: how it works, illustrative setup around the real 5.08 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMA: how it works, illustrative setup around the real 5.08 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMA: how it works, illustrative setup around the real 5.08 USD price, max profit/loss, breakeven and when to use it. Educational.
IMA technical analysis: range, last 5.08 USD, RSI 34.5, 52w range 4.73 USD–6.3 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IMA in?
ImageneBio (IMA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMA in an uptrend or downtrend?
As of 2026-09-11, IMA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMA's trailing P/E ratio?
IMA's trailing P/E is -1.29, with a market cap of 0.07B. See the earnings research page for full valuation detail.
When does IMA next report earnings?
IMA is next scheduled to report earnings on 2026-07-23, with a consensus EPS estimate of -0.97667 USD.